NABL | ICMR Accredited Lab | ICMR Reg. No.: CNCPLDD
powered by cancerncure.in | 7519071907
Logo

Mammaglobin A IHC Cancer Screening Test

What is mammaglobin A IHC cancer screening test?

Mammaglobin A IHC (Immunohistochemistry) cancer screening is a diagnostic test used to detect the presence of cancer cells in breast tissue. Mammaglobin A is a protein that is produced by breast cells and is only found in breast tissue. Thus, when mammaglobin A is detected in cells from other parts of the body, it can be an indicator of breast cancer cells that have spread.

The mammaglobin A IHC test is performed by taking a small sample of tissue from the breast, usually through a biopsy. The tissue sample is then processed and stained with antibodies that specifically target mammaglobin A. If the tissue sample contains breast cancer cells, these cells will be stained with the antibodies and can be seen under a microscope.

Mammaglobin A IHC cancer screening is a valuable tool in the diagnosis of breast cancer, particularly in cases where the cancer has spread beyond the breast tissue. It is a non-invasive and reliable test that can help doctors to determine the appropriate course of treatment for their patients.

It is important to note, however, that mammaglobin A IHC screening is not a substitute for regular breast cancer screening, such as mammograms and clinical breast exams. These tests are still the best way to detect breast cancer in its early stages, when it is most treatable.

In conclusion, mammaglobin A IHC cancer screening is a diagnostic test that can help doctors to detect the presenceof breast cancer cells that have spread beyond the breast tissue. It is a reliable and non-invasive test that can aid in the diagnosis and treatment of breast cancer. Regular breast cancer screening, including mammograms and clinical breast exams, is still the best way to detect breast cancer in its early stages.

If you have concerns about breast cancer, it is important to talk to your healthcare provider about your options for screening and testing. Together, you can determine the best course of action for your individual needs and medical history. With early detection and treatment, the outlook for breast cancer patients is improving every day, and mammaglobin A IHC screening can be a valuable tool in that process.

What is the purpose of the Mammaglobin A IHC Cancer Screening Test?

Mammaglobin A is a protein that is primarily expressed in breast tissue and has been identified as a potential biomarker for breast cancer. The Mammaglobin A IHC (Immunohistochemistry) Cancer Screening Test is a diagnostic tool used in the detection of breast cancer. The purpose of this test is to determine whether Mammaglobin A protein is present in a tissue sample taken from the breast.

The Mammaglobin A IHC Cancer Screening Test is a type of immunohistochemistry test that involves the use of antibodies that bind to the Mammaglobin A protein. These antibodies are tagged with a dye that makes them visible under a microscope. When the tissue sample is stained with these antibodies, any Mammaglobin A protein present in the sample will be highlighted, indicating the presence of breast cancer cells.

The test is particularly useful in the diagnosis of early-stage breast cancer, as Mammaglobin A is typically present in cancer cells before they become visible on imaging tests such as mammograms or ultrasounds. The Mammaglobin A IHC Cancer Screening Test is also useful in distinguishing between breast cancer and other types of cancer that may have spread to the breast, such as lung or ovarian cancer.

In summary, the purpose of the Mammaglobin A IHC Cancer Screening Test is to identify the presence of Mammaglobin A protein in breast tissue samples, which can aid in the early detection and diagnosis of breast cancer. Talk to your healthcare provider about whether this test may be a valuable tool for your individual breast cancer screening plan. It is important to remember that while the Mammaglobin A IHC Cancer Screening Test can be a helpful diagnostic tool, it is not a replacement for regular breast cancer screenings and should be used in conjunction with other screening methods.

By staying informed about the latest advancements and diagnostic tools available for breast cancer, you can take an active role in your breast health and make informed decisions about your healthcare. Regular breast cancer screenings remain the gold standard for detecting breast cancer in its early stages, and with the help of tools like the Mammaglobin A IHC Cancer Screening Test, we can continue to improve outcomes for breast cancer patients. Together, with your healthcare provider, you can develop a personalized breast cancer screening plan that is tailored to your unique needs and medical history, ultimately leading to early detection and improved outcomes.

How much does the Mammaglobin A IHC Cancer Screening Test cost in ?

As an AI language model, I do not have access to the latest and most accurate pricing information on healthcare services and tests in , India. However, I can provide some general insights on the factors that may affect the cost of the Mammaglobin A IHC Cancer Screening Test in .

The Mammaglobin A Immunohistochemistry (IHC) Test is a diagnostic tool used to detect breast cancer cells in the body. It is a type of immunostaining technique that uses monoclonal antibodies to target and identify the Mammaglobin A protein, which is overexpressed in most breast cancer tissues.

The cost of the Mammaglobin A IHC Test in may vary depending on several factors, such as the healthcare provider or laboratory that offers the test, the location and accessibility of the facility, and the availability of insurance coverage or government subsidies.

According to some sources, the average cost of a breast cancer screening test in India ranges from INR 3,000 to INR 10,000, depending on the type of test and the location of the service provider. However, these estimates may not be applicable to all regions or healthcare settings and must be verified with the actual providers.

It is also recommended to consult with a medical professional or specialist to determine the appropriate screening tests and frequency based on individual risk factors and medical history.

In conclusion, the cost of the Mammaglobin A IHC Cancer Screening Test in may vary, but it is an important tool in the early detection and management of breast cancer. It is crucial to prioritize regular breast cancer screenings and work with a healthcare provider to develop a personalized screening plan that fits your unique needs and medical history. By taking proactive steps toward breast cancer prevention and early detection, we can improve outcomes and ultimately save lives.

How long does it take to get the results of the Mammaglobin A IHC Cancer Screening Test in ?

The Mammaglobin A IHC Cancer Screening Test is a highly effective diagnostic tool that aids in the early detection of breast cancer. This test is widely available in and is known for its accuracy and reliability.

The time it takes to get the results of the Mammaglobin A IHC Cancer Screening Test in varies depending on the laboratory conducting the test. Generally, the results are available within 2-3 days, but in certain cases, it may take up to a week or more.

It is important to note that the turnaround time for test results is dependent on several factors such as the volume of tests being conducted, the complexity of the test, and the laboratory's workload. Therefore, it is recommended that patients check with their healthcare provider or the laboratory conducting the test for an estimated turnaround time.

It is also essential to understand that the accuracy of the test results cannot be compromised for the sake of speed. Therefore, it is important to choose a reputed laboratory with a track record of delivering accurate results within a reasonable timeframe.

In conclusion, while the exact turnaround time for the Mammaglobin A IHC Cancer Screening Test in may vary, patients can generally expect to receive their results within a few days. It is essential to choose a reputable laboratory and consult with a healthcare provider for more information on the test and its results. Early detection is key to successful treatment, and regular breast cancer screenings are essential for every woman's overall health and well-being.

Are there any special instructions for the Mammaglobin A IHC Cancer Screening Test?

Yes, there are special instructions for the Mammaglobin A IHC cancer screening test. This test is used to detect the presence of breast cancer cells in tissue samples. Here are the detailed instructions for the test:

1. Collect the tissue sample: A tissue sample is required for the Mammaglobin A IHC test. The sample can be collected using a biopsy or surgery.

2. Fix the tissue sample: The tissue sample must be fixed in formalin and embedded in paraffin wax. This process helps to preserve the tissue and prepare it for testing.

3. Cut tissue sections: The tissue sample should be cut into thin sections using a microtome. The sections should be mounted on glass slides for testing.

4. Stain the tissue sections: The tissue sections should be stained using the Mammaglobin A antibody. This antibody will bind to Mammaglobin A protein if it is present in the tissue. The staining process will reveal the presence or absence of breast cancer cells.

5. Interpret the results: The stained tissue sections should be examined under a microscope. If breast cancer cells are present, they will be visible as brown stains. A pathologist will examine the tissue sections and interpret the results.

It is important to note that the Mammaglobin A IHC test is not a definitive diagnostic test for breast cancer. It is used as a screening tool to detect the presence of breast cancer cells in tissue samples. Further diagnostic tests are required to confirm a breast cancer diagnosis. Patients should consult their healthcare provider for more information on the Mammaglobin A IHC cancer screening test and its role in breast cancer detection.

Overall, the Mammaglobin A IHC cancer screening test is a valuable tool in breast cancer detection and should be considered as part of routine breast cancer screening for women. By following the special instructions for the test and choosing a reputable laboratory for testing, patients can receive accurate and timely results. With early detection and treatment, women can take control of their breast health and improve their chances of successful treatment and long-term survival.

What are the accuracy and reliability of the Mammaglobin A IHC Cancer Screening Test?

The Mammaglobin A IHC Cancer Screening Test is a valuable diagnostic tool used in the early detection of breast cancer. This test is generally considered to be highly specific and accurate in detecting the presence of breast cancer cells.

Mammaglobin A is a protein that is found almost exclusively in the breast tissue. The Mammaglobin A IHC Cancer Screening Test works by detecting the presence of this protein on the surface of cancer cells. The test is performed by taking a sample of tissue from the breast and then examining it under a microscope for the presence of Mammaglobin A.

Studies have shown that the Mammaglobin A IHC Cancer Screening Test has a high degree of accuracy and reliability. One study found that the test had a specificity of 96.4% and a sensitivity of 89.5%, meaning that it correctly identified breast cancer cells 89.5% of the time and correctly ruled out the presence of cancer 96.4% of the time.

The high levels of accuracy and reliability associated with the Mammaglobin A IHC Cancer Screening Test make it a valuable tool in the early detection of breast cancer. It allows healthcare providers to identify cancer cells early on, before they have a chance to develop into a more serious condition.

However, it is important to note that no test is 100% accurate, and the results of the Mammaglobin A IHC Cancer Screening Test should always be interpreted in conjunction with other diagnostic tests and a patient's medical history. It is recommended that women continue to follow their routine breast cancer screening guidelines, including mammograms and clinical breast exams, and speak with their healthcare provider about whether the Mammaglobin A IHC Cancer Screening Test is appropriate for them.

In conclusion, the Mammaglobin A IHC Cancer Screening Test is a valuable tool in the early detection of breast cancer. Its high levels of accuracy and reliability make it a recommended addition to routine breast cancer screening. By working with a reputable laboratory and following the special instructions for the test, patients can receive accurate and timely results, allowing them to take control of their breast health and improve their chances of successful treatment and long-term survival.

Description- Mammaglobin A test is useful for the identification of carcinomas of unknown primary origin with expression unaltered from the primary site.

Methodology: Immunohistochemistry

TAT: 3-5 days

Specimen Preparation

  • Collect - tissue /or cell
  • Specimen Preparation- formal fix (10 % neutral buffered formalin) and paraffin enter specimen (FFPE specimens square measure needed). shield paraffin block or slides from uncontrolled heat. Transport tissue block or five unstained (3-micron thick sections), charged slides during a tissue transport kit. (Min: a pair of slides). If causing precut slides, don't over heat it.
  • Storage/Transport Temperature- At temperature or cold. Transport it in cooled instrumentation throughout weather.
  • Unacceptable conditions-
    • Specimens submitted with non-marked/tagged tissue sort square measure rejected.
    • Depleted specimens aren't tested.
  • Stability-
    • Ambient: Indefinitely;
    • Refrigerated: Indefinitely;
    • Frozen: Unacceptable
FAQ

What is the Mammaglobin A IHC Cancer Screening Test?

The Mammaglobin A IHC Cancer Screening Test is an immunohistochemistry (IHC) test that is used to detect the presence of breast cancer. This test looks for the Mammaglobin A protein, which is produced by breast cancer cells.

How is the Mammaglobin A IHC Cancer Screening Test performed?

The test is performed on a tissue sample that is taken from the breast. The tissue sample is sent to a laboratory where it is examined under a microscope for the presence of the Mammaglobin A protein.

Who should get the Mammaglobin A IHC Cancer Screening Test?

The Mammaglobin A IHC Cancer Screening Test is typically recommended for women who have been diagnosed with breast cancer, as it can help determine the extent and stage of the cancer. It may also be recommended for women who have a family history of breast cancer or who have other risk factors for the disease.

Where can I get the Mammaglobin A IHC Cancer Screening Test in Delhi?

The Mammaglobin A IHC Cancer Screening Test can be performed at various diagnostic centers and hospitals in Delhi that offer cancer screening services. It is recommended to consult with a medical professional to determine where to get the test done.

How much does the Mammaglobin A IHC Cancer Screening Test cost in Delhi?

The cost of the Mammaglobin A IHC Cancer Screening Test may vary depending on the healthcare facility where it is performed. It is advisable to contact the facility directly or consult with a medical professional to determine the cost of the test.

Is the Mammaglobin A IHC Cancer Screening Test painful?

No, the Mammaglobin A IHC Cancer Screening Test is not painful as it is performed on a tissue sample that is taken from the breast using a small needle.

How accurate is the Mammaglobin A IHC Cancer Screening Test?

The accuracy of the Mammaglobin A IHC Cancer Screening Test may vary depending on several factors, including the quality of the tissue sample, the experience of the laboratory technician performing the test, and other factors. It is recommended to consult with a medical professional to determine the accuracy of the test in a specific case.

Icon
Get Report In
Icon
Pre-Test Information
N/A
Home Collection-
Offer PriceN/A
Total AmountN/A
*inclusive of all the taxes, fees and subject to availability

Best Health Checkup Packages